Muted Inhibitors
The group of chemical compounds known as Muted Inhibitors primarily work through the modulation of endocytic pathways and neurotransmitter signaling. Dopamine receptor antagonists such as Chlorpromazine and Haloperidol, as well as vesicular monoamine transporter (VMAT) inhibitors like Reserpine and Tetrabenazine, reduce the function of the dopamine-dependent endocytic pathway that Muted is involved in. This can indirectly inhibit the functional activity of Muted as it is involved in the biogenesis of endosomes, and the decreased endocytic activity due to the lowered dopamine signaling could lead to the functional inhibition of Muted.
On the other hand, non-competitive NMDA receptor antagonists such as Amantadine, Memantine, and Ketamine can reduce glutamate signaling, which may indirectly inhibit the functional activity of Muted. Muted is involved in endocytic pathways that can be influenced by glutamate receptor activity, thus a reduction in this activity can lead to decreased functional activity of Muted. Furthermore
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a dopamine receptor antagonist. By blocking dopamine receptors, it can reduce the function of the dopamine-dependent endocytic pathway that Muted is involved in, thus indirectly inhibiting the functional activity of Muted. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is another dopamine receptor antagonist. It can reduce the function of the dopamine-dependent endocytic pathway, which Muted is involved in, thus indirectly inhibiting the functional activity of Muted. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $137.00 $414.00 | 1 | |
Reserpine inhibits vesicular monoamine transporters (VMATs), leading to depletion of monoamines such as dopamine from synaptic vesicles. This can reduce the function of the dopamine-dependent endocytic pathway that Muted is involved in, thus indirectly inhibiting the functional activity of Muted. | ||||||
Tetrabenazine | 58-46-8 | sc-204338 sc-204338A | 10 mg 50 mg | $168.00 $721.00 | ||
Tetrabenazine is a VMAT inhibitor that can deplete synaptic vesicles of monoamines such as dopamine. This can reduce the function of the dopamine-dependent endocytic pathway that Muted is involved in, thus indirectly inhibiting the functional activity of Muted. | ||||||
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
Amantadine is an antiviral that also acts as a non-competitive NMDA receptor antagonist. By reducing glutamate signaling, it may indirectly inhibit the functional activity of Muted, as it is involved in endocytic pathways that can be influenced by glutamate receptor activity. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
Memantine is a non-competitive NMDA receptor antagonist. By reducing glutamate signaling, it may indirectly inhibit the functional activity of Muted, as Muted is involved in endocytic pathways that can be influenced by glutamate receptor activity. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine is a local anesthetic that blocks voltage-gated sodium channels, reducing neuronal excitability. This can lead to decreased endocytic activity, indirectly inhibiting the functional activity of Muted. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of vacuolar-type H+-ATPase (V-ATPase) that can disrupt endosomal acidification. This can inhibit the endocytic pathway where Muted functions, leading to decreased functional activity of Muted. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A is another specific inhibitor of V-ATPase that can disrupt endosomal acidification. This can inhibit the endocytic pathway where Muted functions, leading to decreased functional activity of Muted. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a non-competitive inhibitor of the GTPase activity of dynamin, a key protein involved in endocytosis. By inhibiting dynamin, dynasore can disrupt the endocytic pathway that Muted is involved in, thus indirectly inhibiting the functional activity of Muted. | ||||||